These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16002726)

  • 1. Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice.
    Hamada N; Kuwano K; Yamada M; Hagimoto N; Hiasa K; Egashira K; Nakashima N; Maeyama T; Yoshimi M; Nakanishi Y
    J Immunol; 2005 Jul; 175(2):1224-31. PubMed ID: 16002726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis.
    Yamada M; Kuwano K; Maeyama T; Yoshimi M; Hamada N; Fukumoto J; Egashira K; Hiasa K; Takayama K; Nakanishi Y
    J Clin Pathol; 2007 Aug; 60(8):916-20. PubMed ID: 17018685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.
    Inoshima I; Kuwano K; Hamada N; Hagimoto N; Yoshimi M; Maeyama T; Takeshita A; Kitamoto S; Egashira K; Hara N
    Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L1038-44. PubMed ID: 15064241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice.
    Wang X; Zhu H; Yang X; Bi Y; Cui S
    Pathology; 2010; 42(5):457-62. PubMed ID: 20632823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the receptor for advanced glycation end-products in lung fibrosis.
    He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
    Zhao Q; Ishibashi M; Hiasa K; Tan C; Takeshita A; Egashira K
    Hypertension; 2004 Sep; 44(3):264-70. PubMed ID: 15262905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice.
    Lee SH; Lee EJ; Lee SY; Kim JH; Shim JJ; Shin C; In KH; Kang KH; Uhm CS; Kim HK; Yang KS; Park S; Kim HS; Kim YM; Yoo TJ
    Exp Lung Res; 2014 Apr; 40(3):117-25. PubMed ID: 24624895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12.
    Maeyama T; Kuwano K; Kawasaki M; Kunitake R; Hagimoto N; Hara N
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1128-37. PubMed ID: 11350791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
    Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
    Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of bleomycin-induced pneumopathy by TNF.
    Kuroki M; Noguchi Y; Shimono M; Tomono K; Tashiro T; Obata Y; Nakayama E; Kohno S
    J Immunol; 2003 Jan; 170(1):567-74. PubMed ID: 12496444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in expression of cytokines in polyhexamethylene guanidine-induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis.
    Kim MS; Kim SH; Jeon D; Kim HY; Lee K
    Toxicology; 2018 Jan; 393():185-192. PubMed ID: 29175452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.
    Segel MJ; Aqeilan R; Zilka K; Lorberboum-Galski H; Wallach-Dayan SB; Conner MW; Christensen TG; Breuer R
    Int J Exp Pathol; 2005 Oct; 86(5):279-88. PubMed ID: 16191100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of bleomycin-induced lung fibrosis.
    Izbicki G; Segel MJ; Christensen TG; Conner MW; Breuer R
    Int J Exp Pathol; 2002 Jun; 83(3):111-9. PubMed ID: 12383190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.